Imagine Boston 2030

Imagine Boston 2030
Author: City Of Boston
Publisher:
Total Pages:
Release: 2017-09-08
Genre:
ISBN: 9781389647642

Today, Boston is in a uniquely powerful position to make our city more affordable, equitable, connected, and resilient. We will seize this moment to guide our growth to support our dynamic economy, connect more residents to opportunity, create vibrant neighborhoods, and continue our legacy as a thriving waterfront city.Mayor Martin J. Walsh's Imagine Boston 2030 is the first citywide plan in more than 50 years. This vision was shaped by more than 15,000 Boston voices.

The Pig Book

The Pig Book
Author: Citizens Against Government Waste
Publisher: Macmillan
Total Pages: 212
Release: 2005-04-06
Genre: Business & Economics
ISBN: 9780312343576

A compendium of the most ridiculous examples of Congress's pork-barrel spending.

For the People, Against the Tide

For the People, Against the Tide
Author: Kathleen M. Teahan
Publisher:
Total Pages: 162
Release: 2021-10-04
Genre: Political Science
ISBN: 9781737698524

For the People, Against the Tide is part topical memoir, part handbook for concerned citizens thinking about getting involved in the political process, but intimidated by practically everything in our modern American political process. This first-hand account of the reality of holding elected office demystifies the legislative process and the realities of modern political life. Kathleen Teahan, a Massachusetts State Legislator from 1997-2007, pulls back the curtain on the challenges of serving in government. With stories and specific examples from her ten years as a state representative, Teahan offers the inspiration and the steps concerned citizens can take to speak up, use the power of their vote, volunteer in campaigns, and run for office. Read below, what two former Massachusetts governors, Michael Dukakis and Deval Patrick, say about For the People, Against the Tide. "What do state legislators do? In fact, if they are public servants like Kathy Teahan, they do a lot-seven days a week. Yes, they legislate, but they never stop working in their districts in countless ways. This book and Kathy Teahan tell you how and why-as critical links between citizens and their governments at every level. And she does it in a way that helps us understand just how important they are in bringing state and local governments directly to the people they serve." Michael S. Dukakis, Governor of Massachusetts (1975-1979; 1983-1991), 1988 Democratic Party Presidential Nominee "As a persistent legislator, and a careful listener, Kathy Teahan brought her faith in our civic values and in people to our state, influencing jaundiced veteran politicians and wide-eyed newcomers alike, and gave voice to the voiceless. Her memoir reminds us of the power of her optimism." Deval Patrick, Governor of Massachusetts (2007-2017)

Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 483
Release: 2017-09-28
Genre: Medical
ISBN: 0309459575

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.